Results
Type
Country of origin
Qualifications

Deferiprone | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Deferiprone. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Emcure Pharma


Type: Producer
Origin: India
India
Aarti Industries


Type: Producer
Origin: India
India
Cadila Healthcare


Type: Producer
Origin: India
India
Cipla


Type: Producer
Origin: India
India

Looking for Deferiprone 30652-11-0?

API | Excipient name:
Deferiprone 
Synonyms:
Deferipron, Deferiprona, Deferiproni, Deferipronum, Deferypron, Dimethylhydroxypyridone, Ferriprox  
Cas Number:
30652-11-0 
DrugBank number:
DB08826 
Unique Ingredient Identifier:
2BTY8KH53L

About Deferiprone

Here is a short description about Deferiprone. Deferiprone is an oral iron chelator used as a second line agent in thalassemia syndromes when iron overload from blood transfusions occurs. Thalassemias are a type of hereditary anaemia due a defect in the production of hemoglobin. As a result, erythropoiesis, the production of new red blood cells, is impaired. FDA approved on October 14, 2011.

You can ask the supplier for more technical information about the product.

Deferiprone manufacturers | traders | suppliers
We have 4 companies offering Deferiprone from 1 different countries.

Get in contact with the supplier of your choice:

  • Emcure Pharma from India
  • Aarti Industries from India
  • Cadila Healthcare from India
  • Cipla from India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.